Patents by Inventor Dulal Panda

Dulal Panda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180344710
    Abstract: The present invention provides for a drug delivery system for anti-cancer compound and method of preparation thereof.
    Type: Application
    Filed: February 23, 2017
    Publication date: December 6, 2018
    Inventors: Radhika POOJARI, Dulal PANDA, Rohit SRIVASTAVA
  • Publication number: 20180194789
    Abstract: The present invention relates to the anticancer property studies of a series of chiral palladium N-heterocyclic carbene complexes of the general formula of (NHC)2PdX2 [NHC=chiral N-heterocyclic carbene ligand 1-(1S,2S,5R/1R,2R,5S)-menthyl-4-(R)-1,2,4-triazol-5-ylidene, wherein R=Et, allyl and CH2Ph; X=Br or OCOCF3], as designated by, (1S,2S,5R)-(1-3)b and (1R,2R,5S)-(1-3)b, (1S,2S,5R)-(1, 3)c and (1R,2R,5S)-(1, 3)c represented by formula (Ig, Ih) below. The present invention further investigates the influence of chirality on the anticancer activity, wherein the enantiomeric pairs of present chiral palladium N-heterocyclic carbene complexes of formula (Ig, Ih) shows no differential activity based on optical isomerism despite all of the palladium complexes exhibiting high anti-proliferative activity towards a variety of cancer cells.
    Type: Application
    Filed: November 8, 2017
    Publication date: July 12, 2018
    Inventors: Anuj Kumar, Afsana Naaz, Prakasham Ayyampudur Palanisamy, Dulal Panda, Prasenjit Ghosh
  • Publication number: 20170128592
    Abstract: The present invention provides targeted polymeric nano-complexes for delivery of drugs such as anti-mitotic agents or anti-cancer agents. The present invention also provides a process for the preparation of such targeted nano-complexes.
    Type: Application
    Filed: September 27, 2016
    Publication date: May 11, 2017
    Inventors: Radhika POOJARI, Dulal Panda, Rohit Srivastava
  • Publication number: 20160168195
    Abstract: This invention relates to oligopeptides having general formula (I). The invention also relates to the process of preparation thereof, wherein the said compounds are selective anti-cancer agents over a panel of human cancer cell lines. Further, this invention relates that said anti-cancer peptides are prepared by a novel method.
    Type: Application
    Filed: October 29, 2015
    Publication date: June 16, 2016
    Inventors: Tushar Kanti CHAKRABORTY, Praveen Kumar GAJULA, Dulal PANDA, Jayant ASTHANA
  • Patent number: 9200034
    Abstract: This invention relates to oligopeptides having general formula (I). The invention also relates to the process of preparation thereof, wherein the said compounds are selective anti-cancer agents over a panel of human cancer cell lines. Further, this invention relates that said anti-cancer peptides are prepared by a novel method.
    Type: Grant
    Filed: January 23, 2012
    Date of Patent: December 1, 2015
    Assignee: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    Inventors: Tushar Kanti Chakraborty, Praveen Kumar Gajula, Dulal Panda, Jayant Asthana
  • Publication number: 20140005121
    Abstract: This invention relates to oligopeptides having general formula (I). The invention also relates to the process of preparation thereof, wherein the said compounds are selective anti-cancer agents over a panel of human cancer cell lines. Further, this invention relates that said anti-cancer peptides are prepared by a novel method.
    Type: Application
    Filed: January 23, 2012
    Publication date: January 2, 2014
    Applicant: Council of Scientific & Industrial Research
    Inventors: Tushar Kanti Chakraborty, Praveen Kumar Gajula, Dulal Panda, Jayant Asthana